Renzapride Terminated Phase 3 Trials for Constipation-predominant Irritable Bowel Syndrome (IBS-C)

IndicationsStatusPurposePhase
TerminatedNot Available3
clinicaltrials.gov IdentifierTitleDrugs
NCT00607971Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)